Literature DB >> 22825364

Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease.

Ilus Tuire1, Lähdeaho Marja-Leena, Salmi Teea, Haimila Katri, Partanen Jukka, Saavalainen Päivi, Huhtala Heini, Mäki Markku, Collin Pekka, Kaukinen Katri.   

Abstract

OBJECTIVES: In celiac disease, complete histological normalization of the small-intestinal mucosa occurs in only 8-20% of adult patients after commencing a gluten-free diet. Intraepithelial lymphocytosis may persist for years while villous morphology normalizes. Factors contributing to this and the clinical relevance of persistent intraepithelial lymphocytosis were here investigated.
METHODS: Altogether 177 adult celiac disease patients adhering to a long-term strict gluten-free diet were enrolled. Co-morbidities, ongoing medications, and consumption of oats and wheat-starch were recorded. Small-bowel morphology and intraepithelial lymphocyte count as well as laboratory parameters of malabsorption were evaluated. Gastrointestinal symptoms and psychological well-being were measured by structured questionnaires.
RESULTS: In all, 170 (96%) out of the 177 patients evinced normal villous architecture and 7 (4%) villous atrophy. Among patients with normal villous structure, 96 (56%) had persistent intraepithelial lymphocytosis and 74 (44%) completely normal small-intestinal mucosa. Consumption of oats was the only factor contributing to the persistent intraepithelial lymphocytosis. Co-morbidities, Helicobacter pylori gastritis, drugs, or wheat-starch in the diet had no effect. The clinical outcome of the patients with persistent intraepithelial lymphocytosis was good, since no signs of malabsorption, excess malignancies, increase in gastrointestinal symptoms, or impaired quality of life were associated with it when compared to subjects with completely normal mucosa. The only outcome found in this study was a significantly lower, although normal villous height-crypt depth ratio among the patients with persistent intraepithelial lymphocytosis as compared to those with completely normal mucosa.
CONCLUSIONS: Despite excellent villous recovery in this study, persistent intraepithelial lymphocytosis was still common among celiac disease patients on a long-term strict gluten-free diet. Consumption of oats was associated with persistent duodenal lymphocytosis and this calls for further investigations. The prognosis of patients with persistent intraepithelial lymphocytosis seems to be good while adhering to a gluten-free diet for a mean of 11 years.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825364     DOI: 10.1038/ajg.2012.220

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  35 in total

1.  Predictors and Significance of Incomplete Mucosal Recovery in Celiac Disease After 1 Year on a Gluten-Free Diet.

Authors:  Henna Pekki; Kalle Kurppa; Markku Mäki; Heini Huhtala; Harri Sievänen; Kaija Laurila; Pekka Collin; Katri Kaukinen
Journal:  Am J Gastroenterol       Date:  2015-06-02       Impact factor: 10.864

Review 2.  Practical insights into gluten-free diets.

Authors:  Jacalyn A See; Katri Kaukinen; Govind K Makharia; Peter R Gibson; Joseph A Murray
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-22       Impact factor: 46.802

Review 3.  Support for patients with celiac disease: A literature review.

Authors:  Jonas F Ludvigsson; Tim Card; Paul J Ciclitira; Gillian L Swift; Ikram Nasr; David S Sanders; Carolina Ciacci
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

4.  Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease.

Authors:  Martina Klemenak; Jernej Dolinšek; Tomaž Langerholc; Diana Di Gioia; Dušanka Mičetić-Turk
Journal:  Dig Dis Sci       Date:  2015-07-02       Impact factor: 3.199

5.  Is it gluten-free? Relationship between self-reported gluten-free diet adherence and knowledge of gluten content of foods.

Authors:  Jocelyn A Silvester; Dayna Weiten; Lesley A Graff; John R Walker; Donald R Duerksen
Journal:  Nutrition       Date:  2016-02-13       Impact factor: 4.008

6.  ACG clinical guidelines: diagnosis and management of celiac disease.

Authors:  Alberto Rubio-Tapia; Ivor D Hill; Ciarán P Kelly; Audrey H Calderwood; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2013-04-23       Impact factor: 10.864

7.  Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study.

Authors:  Benjamin Lebwohl; Fredrik Granath; Anders Ekbom; Karin E Smedby; Joseph A Murray; Alfred I Neugut; Peter H R Green; Jonas F Ludvigsson
Journal:  Ann Intern Med       Date:  2013-08-06       Impact factor: 25.391

8.  Risk of renal disease in patients with both type 1 diabetes and coeliac disease.

Authors:  Kaziwe Mollazadegan; Michael Fored; Sigrid Lundberg; Johnny Ludvigsson; Anders Ekbom; Scott M Montgomery; Jonas F Ludvigsson
Journal:  Diabetologia       Date:  2014-03-25       Impact factor: 10.122

Review 9.  Role of oats in celiac disease.

Authors:  Isabel Comino; María de Lourdes Moreno; Carolina Sousa
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

10.  Understanding celiac disease monitoring patterns and outcomes after diagnosis: A multinational, retrospective chart review study.

Authors:  Knut Ea Lundin; Ciaran P Kelly; David S Sanders; Kristina Chen; Sheena Kayaniyil; Sisi Wang; Rajvi J Wani; Caitlin Barrett; Shakira Yoosuf; Ellen S Pettersen; Robert Sambrook; Daniel A Leffler
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.